Arimidex 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FG3NJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,490
Award facts
- Contract value 100% obligated
- $19,490.30 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $19,490.30 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 20, 2026, for the supply of Arimidex 1 mg tablets (30-count units). This is a non-set-aside contract with a completion date of January 21, 2026, with performance fulfillment at the awardee's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., operates as a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications and medical supplies to support military healthcare programs worldwide.
This delivery order represents routine pharmaceutical procurement under an established federal contracting relationship. AmerisourceBergen's extensive federal contract portfolio demonstrates its capability to meet DLA requirements through open competition, with contracts consistently structured as firm fixed-price arrangements across multiple therapeutic domains. The DLA Troop Support Medical IDC under which this order was placed encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies required across military healthcare systems globally, including support for the Defense Health Agency and other government healthcare entities.
Quick answers
Who was awarded contract SPE2DR26FG3NJ?
SPE2DR26FG3NJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FG3NJ worth?
The government has obligated $19,490 on SPE2DR26FG3NJ.
Is contract SPE2DR26FG3NJ an order under another contract?
Yes. SPE2DR26FG3NJ is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3NJ competed?
The extent of competition for SPE2DR26FG3NJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award